Premise, promise and challenges of MDMA assisted therapy for PTSD.
作者信息
Madero Santiago, Alvarez Oscar D
机构信息
University Hospital Clinic of Barcelona, Psychiatry and Psychology Department, Bipolar and Depressive Disorders Unit, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain.
Parc Sanitari Sant Joan de Deu Hospital, Sant Joan de Deu Research Foundation, Spain.
出版信息
Eur Neuropsychopharmacol. 2023 May;70:19-20. doi: 10.1016/j.euroneuro.2023.02.002. Epub 2023 Feb 15.
Abstract
摘要
相似文献
1
Premise, promise and challenges of MDMA assisted therapy for PTSD.
Eur Neuropsychopharmacol. 2023 May;70:19-20. doi: 10.1016/j.euroneuro.2023.02.002. Epub 2023 Feb 15.
2
[Therapeutic investigation with MDMA (ecstasy)].
Med Clin (Barc). 2003 Sep 13;121(8):318; author reply 318-9. doi: 10.1016/s0025-7753(03)73933-5.
3
Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
J Psychopharmacol. 2017 Aug;31(8):967-974. doi: 10.1177/0269881117711712. Epub 2017 Jun 21.
4
MDMA-assisted therapy for PTSD passes phase III trial.
Nat Rev Drug Discov. 2023 Nov;22(11):863. doi: 10.1038/d41573-023-00165-y.
5
MDMA to Treat PTSD in Adults.
Psychopharmacol Bull. 2021 Jun 1;51(3):125-149.
6
Progress and promise for the MDMA drug development program.
Psychopharmacology (Berl). 2018 Feb;235(2):561-571. doi: 10.1007/s00213-017-4779-2. Epub 2017 Nov 20.
7
"Psychedelic Assisted Therapy" Must Not Be Retired.
Am J Psychiatry. 2024 Jan 1;181(1):77-78. doi: 10.1176/appi.ajp.20230667.
8
The re-emergence of hallucinogenic research.
Perspect Psychiatr Care. 2018 Oct;54(4):523-526. doi: 10.1111/ppc.12263. Epub 2018 Feb 20.
9
[MDMA-assisted therapy for PTSD].
Laeknabladid. 2024 May;110(5):254-261. doi: 10.17992/lbl.2024.05.793.
10
MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder.
J Psychoactive Drugs. 2008 Sep;40(3):225-36. doi: 10.1080/02791072.2008.10400637.
引用本文的文献
1
MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-up.
Alcohol Alcohol. 2025 May 14;60(4). doi: 10.1093/alcalc/agaf031.
2
Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.
Adv Sci (Weinh). 2025 Apr;12(15):e2413786. doi: 10.1002/advs.202413786. Epub 2025 Mar 20.
3
What should constitute a control condition in psychedelic drug trials?
Nat Ment Health. 2024 Oct;2(10):1152-1160. doi: 10.1038/s44220-024-00321-2. Epub 2024 Sep 30.
4
Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science.
Transl Behav Med. 2024 Nov 25;14(12):744-752. doi: 10.1093/tbm/ibae053.
5
MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence.
Diseases. 2023 Nov 3;11(4):159. doi: 10.3390/diseases11040159.
6
Can research on entactogens contribute to a deeper understanding of human sexuality?
Pharmacol Rep. 2023 Dec;75(6):1381-1397. doi: 10.1007/s43440-023-00552-7. Epub 2023 Nov 8.
Zotero 插件